Dr. Sreenath Thati Ganganna has been named a 2026 Castle Connolly Top Doctor, marking the third year he has received this esteemed designation. Only 7 percent of the nation's licensed physicians are selected each year as Castle Connolly Top Doctors for their specialties in their respective regions. This recognition underscores Dr. Thati Ganganna's standing as a leading pediatric neurologist and epileptologist at the University of Iowa Stead Family Children's Hospital, which is itself recognized as a Castle Connolly Top Hospital.
As a Clinical Associate Professor and Clinical Director of the Division of Neurology, Dr. Thati Ganganna provides specialized care to pediatric neurology patients across the region. He evaluates and treats a wide range of primary neurological conditions in infants, children, and adolescents. His clinical interests are particularly focused on the management of drug-resistant epilepsy. This includes presurgical evaluation, neurostimulation therapies such as Vagus Nerve Stimulation (VNS), Responsive Neurostimulation (RNS), and Deep Brain Stimulation (DBS), as well as ketogenic dietary therapies. His work is deeply committed to helping children with intractable seizures and supporting their families through the challenges of achieving the best possible quality of life.
The University of Iowa Stead Family Children's Hospital provides a robust infrastructure that supports this advanced care. The hospital features an on-site pediatric epilepsy monitoring unit, an EEG laboratory, and advanced neuroimaging suites. These facilities operate in close collaboration with a highly specialized pediatric neurosurgery team, allowing for seamless coordination between diagnostic testing and clinical consultation. This integrated environment is critical for managing complex neurological disorders effectively.
Dr. Thati Ganganna's extensive education and training form the foundation of his expertise. His background includes a pediatric residency at the University College of Medical Sciences in Delhi, India, followed by a second pediatric residency at Brookdale Hospital and Medical Center in Brooklyn, New York. He completed a fellowship in child neurology at Rainbow Babies & Children's Hospital, University Hospitals & Case Medical Center in Cleveland, Ohio. Furthermore, he completed two additional fellowships at the University of Michigan Health System in Ann Arbor, Michigan: one in epilepsy and a second in clinical neurophysiology with a focus on EEG. He holds board certifications from the American Board of Psychiatry and Neurology in Neurology with Special Qualification in Child Neurology, as well as in the subspecialty of Epilepsy.
Beyond his direct clinical responsibilities, Dr. Thati Ganganna contributes significantly to the future of his field. He serves as the Director of the Epilepsy Fellowship program, where he leads the training of future specialists. His academic contributions include publications in journals such as Stroke, Epilepsy & Behavior Case Reports, Clinical Pediatrics, and the European Journal of Paediatric Neurology. He also serves as an Associate Editor for the Epilepsy section of the Journal of Child Neurology, helping to shape the discourse and standards in pediatric neurology.
The Castle Connolly Top Doctor selection process adds a layer of peer validation to this recognition. Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team. Castle Connolly publishes its Top Doctors list at https://castleconnolly.com and in various print and online partner publications. Nominations are open to all board-certified MDs, DOs, and DPMs, and the selection is based on rigorous criteria including medical education, training, hospital appointments, and disciplinary histories. Importantly, doctors cannot pay to be selected, ensuring the list's integrity is based solely on professional merit.
This repeated recognition matters because it signals consistent excellence and trust within the medical community. For patients and families, especially those dealing with the profound challenges of pediatric neurological conditions like drug-resistant epilepsy, it provides a reliable indicator of where to find highly qualified care. For the healthcare industry, it highlights institutions like the University of Iowa Stead Family Children's Hospital that foster such expertise through integrated facilities and support for both clinical practice and medical education. The implications extend to improved patient outcomes, advancements in treatment protocols through research and training, and the overall elevation of care standards in pediatric neurology on a regional and national level.
